DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Arimoclomol is an investigational drug.
There have been 10 clinical trials for Arimoclomol. The most recent clinical trial was a Phase 3 trial, which was initiated on July 31st 2018.
The most common disease conditions in clinical trials are Amyotrophic Lateral Sclerosis, Sclerosis, and Motor Neuron Disease. The leading clinical trial sponsors are Orphazyme, University of Kansas Medical Center, and CytRx.
There are seventy-five US patents protecting this investigational drug and eight hundred and two international patents.
Recent Clinical Trials for Arimoclomol
|Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial||Orphazyme||Phase 3|
|Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial||University College, London||Phase 3|
|Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial||University of Kansas Medical Center||Phase 3|
Top disease conditions for Arimoclomol
Top clinical trial sponsors for Arimoclomol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Arimoclomol||⤷ Try it Free||Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder||Axovant Sciences GmbH (Basel, CH)||⤷ Try it Free|
|Arimoclomol||⤷ Try it Free||Increase of protein synthesis ameliorates synaptopathy-related neurological disorders||Academia Sinica (Taipei, TW)||⤷ Try it Free|
|Arimoclomol||⤷ Try it Free||Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease||Axovant Sciences GmbH (Basel, CH)||⤷ Try it Free|
|Arimoclomol||⤷ Try it Free||Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same||ENTERIN LABORATORIES, INC. (Merion, PA)||⤷ Try it Free|
|Arimoclomol||⤷ Try it Free||Compositions for treating amyotrophic lateral sclerosis||PHARNEXT (Issy les Moulineaux, FR)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Arimoclomol||Argentina||AR104982||2035-06-12||⤷ Try it Free|
|Arimoclomol||Australia||AU2016276966||2035-06-12||⤷ Try it Free|
|Arimoclomol||Canada||CA2989343||2035-06-12||⤷ Try it Free|
|Arimoclomol||China||CN109562085||2035-06-12||⤷ Try it Free|
|Arimoclomol||European Patent Office||EP3307260||2035-06-12||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|